Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:15 PM
Ignite Modification Date:
2025-12-24 @ 2:15 PM
NCT ID:
NCT02155595
Eligibility Criteria:
Inclusion Criteria:
* women with a diagnosis of osteopenia or osteoporosis as defined by Bone Mineral density (BMD)
* patient treated with BPs for \>5 years
* patients treated with non-BP anti-fracture medications such as...
* estrogens, raloxifene, calcitonin
* treatment naive patients
Exclusion Criteria:
* all men regardless of BMD result
* patients with obvious traumatic AFF
* patients with normal BMD (better than -1.0 T-score at spine or proximal hip)
* unable to take tetracycline
* previous use of teriparatide
* known allergies to the following:
* tetracycline antibiotics
* meperidine
* midazolam
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
50 Years
Study:
NCT02155595
Study Brief:
Protocol Section:
NCT02155595